Can PML Present Without JC Virus Positive Testing?
Yes, progressive multifocal leukoencephalopathy (PML) can absolutely present with negative JC virus testing, and a negative CSF JCV result cannot rule out PML when clinical and radiological findings are suggestive. This is a critical diagnostic pitfall that can delay life-saving treatment.
Why JCV Testing Can Be Falsely Negative
In early-stage PML, JCV may not be detectable in cerebrospinal fluid because viral loads fall below the sensitivity threshold of PCR assays 1. The evidence is compelling:
- In one study of 28 natalizumab-associated PML patients, 16 (57%) initially had undetectable JCV DNA when viral loads were below 500 copies/mL 1
- Among 56 PML patients, 9 (16%) had undetectable JCV DNA in CSF at diagnosis, with smaller lesion volumes significantly increasing the probability of negative PCR results 2
- Even with repeated testing, some patients remain CSF-negative: One documented case required four negative CSF samples before brain biopsy finally confirmed PML by immunohistochemistry 3
The relationship is clear: smaller PML lesions correlate with lower viral loads and higher rates of undetectable JCV DNA 2. This creates a dangerous paradox where early detection through vigilant MRI monitoring may identify PML before CSF testing becomes positive.
The Diagnostic Algorithm When PML Is Suspected
If MRI findings are suggestive of PML, you must proceed as if the patient has PML regardless of negative CSF results 1. Here's the structured approach:
Step 1: Recognize Suspicious MRI Features
Look for these PML-specific characteristics 1:
- Large lesions (>3 cm) in subcortical white matter, not periventricular
- Irregular borders with ill-defined edges toward white matter
- U-fiber involvement extending into gyrus
- No mass effect despite large size
- Progressive expansion over weeks without stabilization
- Cortical gray matter involvement in 50% of cases
Step 2: Manage Based on Clinical Suspicion
When radiological findings suggest PML 1:
- Immediately halt any immunosuppressive therapy (especially natalizumab)
- Classify as "radiologically-suspected PML" and manage accordingly
- Do not wait for positive CSF confirmation to act
Step 3: Repeat Testing Strategy
If initial CSF is negative but suspicion remains high 1:
- Repeat lumbar puncture and CSF JCV PCR testing over several months
- Consider brain biopsy for definitive diagnosis
- Monitor with serial MRI to track lesion progression
Step 4: Consider Alternative Testing
Beyond standard CSF PCR 4:
- Plasma JCV-DNA testing may be positive when CSF is negative (detected in 25% of patients with undetectable CSF JCV-DNA)
- Brain biopsy with immunohistochemistry remains the gold standard when CSF testing is repeatedly negative
Critical Clinical Pitfalls to Avoid
The most dangerous error is excluding PML based solely on negative CSF JCV testing 1. The guidelines explicitly state: "A negative CSF does not exclude PML, and each clinician needs to determine optimal management based on each patient's clinical characteristics" 1.
Additional considerations:
- "Probable PML" can be diagnosed in asymptomatic patients with pathological MRI findings consistent with PML, even with negative initial CSF, and should be managed as PML 1
- Early detection with rapid treatment cessation and immune reconstitution offers better prognosis 1, making aggressive pursuit of diagnosis critical
- PML can occur in apparently immunocompetent patients with cirrhosis, hepatocellular carcinoma, or other subtle immunosuppressive states 5, 6, 7
When to Pursue Brain Biopsy
Brain biopsy should be strongly considered when 1:
- MRI findings are highly suggestive of PML
- Clinical presentation is consistent (subacute progressive deficits over weeks)
- CSF JCV PCR remains negative after repeated testing
- The diagnosis would fundamentally change management
The evidence shows that immunohistochemistry on brain tissue can confirm PML when all CSF testing fails 3, making biopsy the definitive diagnostic tool in ambiguous cases.